Aptose Biosciences Stock (NASDAQ: APTO)
|Day Range0.57 - 0.61||52 Wk Range0.54 - 1.55||Open / Close0.59 / 0.58||Float / Outstanding91M / 92.3M|
|Vol / Avg.107.3K / 193.6K||Mkt Cap53.2M||P/E-||50d Avg. Price0.76|
|Div / Yield-||Payout Ratio-||Total Float91M||EPS-0.11|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Aptose Biosciences (NASDAQ: APTO) through any online brokerage.
There are no as such competitors for Aptose Biosciences.
The latest price target for Aptose Biosciences (NASDAQ: APTO) was reported by RBC Capital on Tuesday, May 10, 2022. The analyst firm set a price target for 6.00 expecting APTO to rise to within 12 months (a possible 940.76% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Aptose Biosciences (NASDAQ: APTO) is $0.5765 last updated September 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aptose Biosciences.
Aptose Biosciences’s Q3 earnings are confirmed for Thursday, November 10, 2022.
There is no upcoming split for Aptose Biosciences.
Aptose Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.